Multimodal Immune Profiling in Thyroid Eye Disease 2253789

A Anne Xuan-Lan Nguyen (University of Oxford) H Hana Andrew (Kennedy Institute of Rheumatology, University of Oxford) J Julia Johnstone (Kennedy Institute of Rheumatology, University of Oxford) K Karene Argoud (Kennedy Institute of Rheumatology, University of Oxford) M Moustafa Attar R Rachael Bashford-Rogers J Joel David (Department of Rheumatology, Oxford University Hospitals) H Helen Turner J Jonathan Norris (Oxford Eye Hospital, Oxford University Hospitals) A Alexander Clarke (Kennedy Institute of Rheumatology, University of Oxford)

Abstract

Abstract Introduction Thyroid Eye Disease (TED) is an autoimmune orbital disorder affecting up to half of patients with Graves’ disease. It progresses from inflammation to fibrosis, leading to proptosis, diplopia, and tissue remodeling. While fibroblast diversity is known to influence disease course, the interplay between immune and stromal compartments remains poorly understood. Here, we apply integrated single-cell and TCR sequencing to define cellular programs and immune—stromal interactions across disease stages in TED. Methods Orbital tissue was obtained during decompression surgery from twelve TED patients (active: Clinical Activity Score ≥3, n = 6; inactive: CAS< 3, n = 6) and two non-inflammatory controls. Single-cell RNA and paired V(D)J sequencing characterized cellular heterogeneity and clonality. Differential expression, pathway enrichment, and ligand—receptor interaction analyses were performed to identify mechanisms associated with disease activity and fibrosis. Results Analysis revealed coordinated immune and fibroblast remodeling across disease stages. Active TED was marked by inflammatory—adipogenic PLIN2+/TNFSF8+ fibroblasts, elevated cytokine signaling, and expanded CD8+ T cell clones expressing activation markers (REL, NFKB1, CD69). Inactive TED showed a shift toward fibrotic and contractile fibroblast states (SPARC, GPX3, TAGLN) and reduced T cell clonality. Cross-talk modeling identified a RORA+ fibroblast subset co-expressing TSHR and IGF1R, potentially mediating T cell—fibroblast signaling via ELL2-associated pathways. Conclusion This study provides a multimodal framework linking immune activation with stromal remodeling in TED. By integrating transcriptional and clonotypic data, we uncover immune—stromal circuits that define inflammatory and fibrotic phases, revealing candidate targets for stage-specific intervention. Funding Source Rhodes Scholarship, Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award, Kennedy Trust Prize Studentship (KTPS), Wellcome Trust Fellowship Topic Categories Immune Mechanisms of Human Disease (HUM)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (10)

A

Anne Xuan-Lan Nguyen

University of Oxford

H

Hana Andrew

Kennedy Institute of Rheumatology, University of Oxford

J

Julia Johnstone

Kennedy Institute of Rheumatology, University of Oxford

K

Karene Argoud

Kennedy Institute of Rheumatology, University of Oxford

M

Moustafa Attar

R

Rachael Bashford-Rogers

J

Joel David

Department of Rheumatology, Oxford University Hospitals

H

Helen Turner

J

Jonathan Norris

Oxford Eye Hospital, Oxford University Hospitals

A

Alexander Clarke

Kennedy Institute of Rheumatology, University of Oxford